Martin Shkreli. Photo: Diego M. Radzinschi/ALM
Shkreli gained notoriety as the “pharma bro” when he was CEO of Turing Pharmaceuticals, where sudden increases in the price of lifesaving drugs attracted media coverage and questions from Congress.
November 18, 2019 at 02:20 PM
1 minute read
The U.S. Supreme Court will not hear an appeal from disgraced pharmaceutical executive Martin Shkreli, according to an order released by the justices Monday.
Shkreli’s 2017 conviction on securities fraud and conspiracy charges was upheld in a summary order from the U.S. Court of Appeals for the Second Circuit in July.
Presented by BigVoodoo
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
